Expanding neuropeptide signalling by multiplying receptor functional states and sub-cellular locations
Neuropeptide signalling is primarily based on activation of G protein-coupled receptors (GPCRs), the largest family of membrane receptors. GPCRs are involved in multiple physiological processes and are important drug targets for many human diseases. In this at a glance review, we focus on the recent advances in GPCR signalling related to the different structural and functional features of complexes involved in G protein- and arrestin-mediated signalling, receptor dimerization and oligomerization, modulation and transactivation of other signalling proteins and receptor compartimentalization. Our goal is to highlight the astonishingly complex and diverse network of signal transduction events that could arise from the activation of neuropeptide receptors.
KeywordsGPCR signalling Biased agonism Receptor dimerization Intracellular signalling G protein
Special thanks to Vito Latis for his help with drawing the figures.
This work was supported by a Thyssen Foundation grant to BC.
- Borroto-Escuela DO, Carlsson J, Ambrogini P, Narvaez M, Wydra K, Tarakanov AO, Li X, Millon C, Ferraro L, Cuppini R et al (2017) Understanding the role of GPCR heteroreceptor complexes in modulating the brain networks in health and disease. Front Cell Neurosci 11:37Google Scholar
- Jeanneteau F, Chao MV (2006) Promoting neurotrophic effects by GPCR ligands. Novartis Found Symp 276:181–189 discussion 189–192, 233–187, 275–181Google Scholar
- Jong YI, Harmon SK, O'Malley KL (2017) GPCR signalling from within the cell. Br J Pharmacol. https://doi.org/10.1111/bph.14023